Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01855386 · ClinicalTrials.gov registry record
The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 126
- Enrollment target
NCT01855386 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 126 participants.
The verdict
NCT01855386 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 126 participants
- Enrollment target
Study Summary
The thought is that Non-Alcoholic Fatty Liver Disease (NAFLD) plays a key role in the progression to prediabetes/T2DM in those with a history of Gestational Diabetes (GDM). The investigators want to know if having a fatty liver will be connected with more glucose abnormalities (higher fasting/oral glucose tolerance test glucose, more insulin resistance) and that a history of GDM will be common in those with NAFLD.
Interventions
- OTHER Subjects with Gestational Diabetes
- OTHER Controls without Gestational Diabetes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01855386
The ClinicalTrials.gov registry entry for NCT01855386 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Subjects with Gestational Diabetes is the first listed.
NCT01855386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01855386 about?
NCT01855386 is a clinical study titled "The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes". The thought is that Non-Alcoholic Fatty Liver Disease (NAFLD) plays a key role in the progression to prediabetes/T2DM in those with a history of Gestational Diabetes (GDM). The investigators want to know if having a fatty liver will be connected with more glucose abnormalities (higher fasting/oral g...
What is the current status of trial NCT01855386?
This trial is currently terminated. The enrollment target is 126 participants. The study started on 2013-01. Estimated completion is 2018-09.
What interventions are being tested in trial NCT01855386?
The interventions under investigation include: Subjects with Gestational Diabetes (OTHER), Controls without Gestational Diabetes (OTHER).
Who is sponsoring clinical trial NCT01855386?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.